Samsung Medical Center
Radiotherapy for breast cancer in the Republic of Korea typically costs from $17,400 to $25,000. The final price depends on the treatment technology, session count, and hospital tier. In the US, similar procedures cost around $40,000 on average. Patients save around 47% compared to the US. Most Korean medical centers include initial consultations and planning in their base pricing.
Bookimed Expert Insight: Choosing a university-affiliated center like Ewha Womans University Medical Center offers specialized care. This JCI-accredited facility focuses specifically on women-only multidisciplinary oncology. While centers like Samsung Medical Center serve over 2,000,000 patients annually, they maintain presidential standards of care. For the best value, consider Seoul National University Hospital (SNUH). It provides fully digitalized treatment protocols used by the South Korean president. This ensures top-tier technology without the extreme price peaks of some private digital-only boutiques.
Why choose the Republic of Korea for radiotherapy for breast cancer?
Access advanced Radiotherapy for breast cancer solutions in trusted clinics .
| Republic of Korea | Turkey | Austria | |
| Radiotherapy for breast cancer | from $17,360 | from $4,500 | from $10,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Radiotherapy for breast cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Radiotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Radiotherapy for breast cancer journey.
Day 1
Day 2 - 3
Day 4 - 5
Week 2 - 6
Week 7
Week 8 - 12
Week 13 - 16
Please note that the timeline and procedures may vary based on the individual patient"s condition and response to treatment.
Dr. Choi specializes in heart failure, transplants, and robotic-assisted heart surgeries at Samsung Medical Center.
The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.
The doctor is a leading specialist in the treatment of breast cancer, with extensive training and experience. He completed his training and internship at Yonsei University Medical Center in South Korea and worked as a surgeon at the Yonsei Cancer Center.
From 2011 to 2013, he served as a consultant professor in the breast cancer department at Anderson University in the USA. His research focuses on the treatment of breast cancer using hormonal and chemotherapy drugs.
The doctor is a member of the Korean Medical Association, the American Society of Clinical Oncology, and the American Association for Cancer Research.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
South Korea’s top hospitals for breast cancer radiotherapy include Samsung Medical Center, Asan Medical Center, and Ewha Womans University Medical Center. These Seoul-based facilities utilize advanced technologies like Novalis and Image-Guided Radiation Therapy (IGRT) within Joint Commission International (JCI) accredited infrastructures to ensure precision oncology care.
Bookimed Expert Insight: While world-ranked centers like Samsung Medical Center serve over 2 million patients annually, they often have significant waiting lists. Data suggests opting for JCI-accredited specialty centers like Ewha Womans University Medical Center provides similar technological standards with more personalized, women-centric care and potentially faster treatment start dates.
Patient Consensus: Patients frequently highlight the availability of 5-week hypo-fractionated courses in Seoul, which successfully reduce fatigue compared to traditional 6-week protocols. Many advise prioritizing stay-integrated facilities like Samsung for better English-speaking coordinator support during daily sessions.
Breast cancer radiotherapy in Korea achieves exceptional success with a 3-year overall survival rate of 98.4% for patients following breast-conserving surgery. The country maintains a 93.6% 5-year relative survival rate for breast cancer, supported by advanced technologies like IMRT and heart-sparing techniques at JCI-accredited Seoul facilities.
Bookimed Expert Insight: While many countries still use conventional 5-week radiation cycles, 89% of Korean practitioners have shifted to hypofractionated radiotherapy. This shorter course offers identical oncologic outcomes but significantly reduces the burden on international patients. Centers like Samsung Medical Center integrate these protocols with Novalis and IGRT technology to ensure presidential-level precision for every patient.
Patient Consensus: Patients report nearly 100% local control for early-stage cases and value the significantly faster treatment access compared to North American or European wait times.
Advanced radiotherapy in South Korea utilizes high-precision technologies like Intensity-Modulated Radiation Therapy (IMRT) and Proton Therapy to target tumors while protecting healthy tissue. Leading Seoul hospitals employ Image-Guided Radiation Therapy (IGRT) and Hypofractionated protocols to improve accuracy and reduce treatment sessions for breast cancer patients.
Bookimed Expert Insight: Data from top-tier facilities like Samsung Medical Center and Severance Hospital shows a shift toward digitalized, error-prevention systems like BESTcare. Choosing clinics with Newsweek World's Best Hospital rankings often ensures access to Novalis systems and RapidArc technology, which complete sessions significantly faster than standard units.
Patient Consensus: Patients frequently highlight that choosing hypofractionation or IMRT in Seoul significantly reduces physical side effects. Many emphasize the importance of verifying English-speaking coordination when discussing complex options like proton therapy for left-sided tumors.
Radiotherapy for breast cancer in the Republic of Korea is generally covered by National Health Insurance for citizens and long-term residents. Coverage typically reaches 70-90% at Joint Commission International-accredited facilities like Severance Hospital. Most patients still face out-of-pocket copayments ranging from $2,200 to $7,400.
Bookimed Expert Insight: While South Korea offers world-class oncology at SNUH and Asan Medical Center, high-demand clinics fill up fast. Patients should verify a hospital carries Grade 1 status through the HIIS app. This designation ensures the highest possible reimbursement rates under the national system.
Patient Consensus: Many patients find total costs 5-10 times cheaper than United States uninsured rates. Most suggest budgeting for a 2-month reimbursement delay and requesting itemized English estimates early.